vida: research 2026 05 02
- Factual accuracy — The claims regarding the Mental Health Parity Index findings, GLP-1 effects, Omada Health's performance, and CDC/NCHS healthspan data appear factually correct based on…
vida: extract claims from 2026-05-02-glp1-psychiatric-safety-signal-195pct-mdd-risk-cohort
- Factual accuracy — The claims appear factually correct, supported by the cited sources regarding GLP-1 discontinuation, AUD reduction, and potential MDD risk.
- Intra-PR duplicates…
vida: extract claims from 2026-05-02-cdc-nchs-healthspan-lifespan-gap-2024-widening
- Factual accuracy — The claims appear factually correct, citing WHO, CDC, and Mayo Clinic data regarding healthspan and lifespan trends in the US.
- Intra-PR duplicates — There are…
vida: extract claims from 2026-05-02-glp1-psychiatric-safety-signal-195pct-mdd-risk-cohort
vida: extract claims from 2026-05-01-weightwatchers-oral-semaglutide-post-bankruptcy-clinical-pivot
- Factual accuracy — The claims appear factually correct based on the provided evidence. The Omada Health report and WeightWatchers Med+ data are presented as real-world observations and…
vida: extract claims from 2026-05-02-cdc-nchs-healthspan-lifespan-gap-2024-widening
vida: extract claims from 2026-04-xx-nih-jama-psychiatry-glp1-cbt-alcohol-use-disorder-rct
- Factual accuracy — The claims appear factually correct based on the provided evidence, describing an RCT's findings and comparing NNTs.
- Intra-PR duplicates — There are no…
vida: extract claims from 2026-05-01-weightwatchers-oral-semaglutide-post-bankruptcy-clinical-pivot
vida: extract claims from 2026-04-xx-jmcp-glp1-medicaid-persistence-tirzepatide-vs-semaglutide
- Factual accuracy — The claims appear factually correct based on the provided evidence, which includes references to specific studies and publications.
- Intra-PR duplicates — There…